MARKSANS PHARMA LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 263.20 INR | +1.87% |
|
+8.75% | +63.68% |
| Aug. 21 | Marksans Pharma Arm Gets UK Regulator's Marketing Nod for Fluoxetine Capsules | MT |
| Aug. 20 | Marksans Pharma Gets US FDA's EIR for Goa, India Unit | MT |
Evolution of the Average Target: Marksans Pharma Limited
Evolution of the Target Price: Marksans Pharma Limited
Changes in Analyst Recommendations: Marksans Pharma Limited
23f7d5aff7d0a69eb3a9de52de.eUVH8MMSa1a90mwhrWWl4uy0h_KFmgQgDfyvivz-P04.Aw8YtfNGBiaPgxxIyh_VsJiZ8pvs23VwSpfty4qYEhpLEA-GpVU_O-y-LQ~cce59a5cc4104df806dca43183d7ac8d
| Analyst Opinion | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Ecart obj. / dr | ||
|---|---|---|---|---|---|---|
| -0.67% | ||||||
| +9.32% | ||||||
| +9.99% | ||||||
| +3.83% | ||||||
| +1.50% | ||||||
| +18.14% | ||||||
| +8.68% | ||||||
| +10.49% | ||||||
| -0.25% | ||||||
| +1.37% | ||||||
| Average | +6.24% | |||||
| Weighted average by Cap. | +7.69% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
258.37INR
Average target price
261.33INR
Spread / Average Target
+1.15%
High Price Target
304.00INR
Spread / Highest target
+17.66%
Low Price Target
215.00INR
Spread / Lowest Target
-16.79%
Analyst Consensus Detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
Annual profits - Rate of surprise
- Stock Market
- Equities
- MARKSANS Stock
- Consensus Marksans Pharma Limited